In our research, we found that FBN2 is highly expressed in normal fibroblasts, and downregulated FBN2 is consistently correlated with the shorter survival of colon cancer patients, this result gives rise to the idea to study the role of FBN2 in a deeper way. The gene discussed is FBN2; the disease is malignant colon neoplasm.